Role of Immunotherapy in AML Treatment Development Immunotherapy is emerging as an important innovation influencing the Acute Myeloid Leukemia Treatment Market. These therapies aim to strengthen the body’s immune system to recognize and destroy leukemia cells. Monoclonal antibodies and immune-modulating treatments are being explored to target cancer-specific markers. Some therapies help immune cells identify leukemia cells more effectively, improving response potential. Ref - https://www.marketresearchfuture.com/reports/acute-myeloid-leukemia-treatment-market-3223